"Starting in the new year, insulin pens will be available at a recommended price of $11 per pen, or a maximum of $55 for a five-pack, Civica said. "You don't need a new prescription," Newsom said at a news conference in Los Angeles. "It's access on the basis of affordability." It is one piece of California's effort to lower prescription drug costs by offering generics as a cheaper alternative."
"Officials said then that they hoped California's emergence as an insulin-maker would prompt prices to collapse. The new pens will be interchangeable with glargine, the generic alternative for more expensive once-a-day injections that regulates blood sugar. As a comparison, the equivalent of a five-pack of Eli Lilly's Rezvoglar sells to pharmacies for more than $88, according to data compiled by the governor's office."
California will begin selling state-branded affordable insulin under the CalRx label on Jan. 1. The state partnered with Civica and Biocon Biologics, invested $50 million, and entered a 10-year agreement to develop the product. Civica will distribute insulin pens nationwide at a recommended $11 per pen or a maximum of $55 for a five-pack, and no new prescription will be required. The pens are interchangeable with glargine, a generic alternative to pricier once-a-day injections. California will also sell naloxone as part of efforts to lower prescription drug costs. About 38 million Americans and roughly 3.5 million Californians have diabetes.
Read at ABC7 San Francisco
Unable to calculate read time
Collection
[
|
...
]